Integration of Bronchoscopic Transesophageal Ultrasound Examination of the Left Adrenal Gland into Routine Lung Cancer Staging Workup: A Prospective Trial.


Journal

Respiration; international review of thoracic diseases
ISSN: 1423-0356
Titre abrégé: Respiration
Pays: Switzerland
ID NLM: 0137356

Informations de publication

Date de publication:
Historique:
received: 18 06 2019
accepted: 16 09 2019
pubmed: 17 10 2019
medline: 7 4 2021
entrez: 17 10 2019
Statut: ppublish

Résumé

Endobronchial ultrasound (EBUS) with transbronchial needle aspiration increases the diagnostic yield of lung cancer staging. The left adrenal gland (LAG) is a common site for lung cancer metastasis. The modality of transesophageal examination with an EBUS bronchoscope (EUS-B) routinely for LAG has not been assessed. The aim of this study was to prospectively assess if evaluation and tissue sampling of the LAG could routinely be implemented in an EBUS procedure. Patients referred for EBUS between March and August 2017 had assessment of the LAG via EUS-B. Fine-needle aspiration (FNA) was performed in cases with a suspicious LAG. The detection rate, procedure time, and learning curve of four experienced EBUS-bronchoscopists was assessed, plus the diagnostic accuracy and complication rate of FNA. In total, 313 consecutive patients were included. The overall LAG detection rate was 87.5%. After the initial learning curve, the detection rate for all four bronchoscopists was >93%. The detection rate did not correlate with any patient characteristics. EUS-B-FNA revealed nine LAG metastases, with a sensitivity, specificity, and accuracy of 75%, 100%, and 99%, respectively. The mean EUS-B operation time was 194.4 s, with 594.8 s for FNA. There were no FNA-associated complications. Evaluation of the LAG with EUS-B could routinely be included in an EBUS procedure if necessary. A high detection rate can be achieved after an initial learning period. FNA of the LAG was feasible and safe. EUS-B of the LAG could be integrated into the usual EBUS/EUS-B procedure in lung cancer staging workup.

Sections du résumé

BACKGROUND BACKGROUND
Endobronchial ultrasound (EBUS) with transbronchial needle aspiration increases the diagnostic yield of lung cancer staging. The left adrenal gland (LAG) is a common site for lung cancer metastasis. The modality of transesophageal examination with an EBUS bronchoscope (EUS-B) routinely for LAG has not been assessed.
OBJECTIVE OBJECTIVE
The aim of this study was to prospectively assess if evaluation and tissue sampling of the LAG could routinely be implemented in an EBUS procedure.
METHODS METHODS
Patients referred for EBUS between March and August 2017 had assessment of the LAG via EUS-B. Fine-needle aspiration (FNA) was performed in cases with a suspicious LAG. The detection rate, procedure time, and learning curve of four experienced EBUS-bronchoscopists was assessed, plus the diagnostic accuracy and complication rate of FNA.
RESULTS RESULTS
In total, 313 consecutive patients were included. The overall LAG detection rate was 87.5%. After the initial learning curve, the detection rate for all four bronchoscopists was >93%. The detection rate did not correlate with any patient characteristics. EUS-B-FNA revealed nine LAG metastases, with a sensitivity, specificity, and accuracy of 75%, 100%, and 99%, respectively. The mean EUS-B operation time was 194.4 s, with 594.8 s for FNA. There were no FNA-associated complications.
CONCLUSIONS CONCLUSIONS
Evaluation of the LAG with EUS-B could routinely be included in an EBUS procedure if necessary. A high detection rate can be achieved after an initial learning period. FNA of the LAG was feasible and safe. EUS-B of the LAG could be integrated into the usual EBUS/EUS-B procedure in lung cancer staging workup.

Identifiants

pubmed: 31618731
pii: 000503396
doi: 10.1159/000503396
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-49

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Kaid Darwiche (K)

Division of Interventional Pneumology, Department of Pulmonary Medicine, Ruhrlandklinik, University Medicine Essen, Essen, Germany, kaid.darwiche@rlk.uk-essen.de.

Jonathan Becker (J)

Division of Interventional Pneumology, Department of Pulmonary Medicine, Ruhrlandklinik, University Medicine Essen, Essen, Germany.

Jane Winantea (J)

Division of Interventional Pneumology, Department of Pulmonary Medicine, Ruhrlandklinik, University Medicine Essen, Essen, Germany.

Ruediger Karpf-Wissel (R)

Division of Interventional Pneumology, Department of Pulmonary Medicine, Ruhrlandklinik, University Medicine Essen, Essen, Germany.

Faustina Funke (F)

Division of Interventional Pneumology, Department of Pulmonary Medicine, Ruhrlandklinik, University Medicine Essen, Essen, Germany.

Elena Stenzel (E)

Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.

Hubertus Hautzel (H)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Thomas Hager (T)

Institute of Pathology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Stephan Eisenmann (S)

Division of Interventional Pneumology, Department of Pulmonary Medicine, Ruhrlandklinik, University Medicine Essen, Essen, Germany.
Department of Pneumology, University Hospital of Martin Luther University, Halle (Saale), Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH